This article has Open Peer Review reports available.
Hyperammonia induces specific liver injury through an intrinsic Ca2+-independent apoptosis pathway
© Li et al.; licensee BioMed Central Ltd. 2014
Received: 20 March 2014
Accepted: 15 August 2014
Published: 22 August 2014
Numerous pathological processes that affect liver function in patients with liver failure have been identified. Among them, hyperammonia is one of the most common phenomena.The purpose of this study was to determine whether hyperammonia could induced specific liver injury.
Hyperammonemic cells were established using NH4Cl. The cells were assessed by MTT, ELISA, and flow cytometric analyses. The expression levels of selected genes and proteins were confirmed by quantitative RT-PCR and western blot analyses.
The effects of 20 mM NH4Cl pretreatment on the cell proliferation and apoptosis of primary hepatocytes and other cells were performed by MTT assays and flow cytometric analyses. Significant increasing in cytotoxicity and apoptosis were only observed in hepatocytes. The cell damage was reduced after adding BAPTA-AM but unchanged after adding EGTA. The expression levels of caspase-3, cytochrome C, calmodulin, and inducible nitric oxide synthase were increased and that of bcl-2 was reduced. The Na+-K+-ATPase activities in hyperammonia liver cells was no signiaficant difference compaired with the control group, but was decreased in astrocytes. NH4Cl pretreatment of primary hepatocytes promoted the activation of mitochondrial permeability transition pores and the mitochondria swelled irregularly.
Hyperammonia induces specific liver injury through an intrinsic Ca2+-independent apoptosis pathway.
Acute liver failure is a multisystem disorder associated with acute renal failure, hypotension, sepsis, coagulopathy, encephalopathy, and cerebral edema . Some researchers have considered that a few hepatocytes are required to restore the liver mass after profound liver injury, while other liver-repopulation and transplantation studies have indicated that bone-marrow stem cells might have the capacity to differentiate into hepatocytes [2–5]. However, the regenerative capacity is insufficient after chronic liver injury . Currently, most researchers consider that the activation, proliferation, migration, differentiation, and survival of cells in the regenerating liver are controlled by a large number of growth factors and cytokines, which expressed at the sites of injury or reach the liver via the circulatory system . Furthermore, a recent study found that severe lactic acidosis was harmful for cirrhotic patients . Our preclinical studies showed that the clinical symptoms of some patients with liver failure, who did not present with symptoms of hepatic encephalopathy (HE) and were treated with blood ammonia-lowering drugs, were greatly relieved. The primary disease process in the liver is complicated because of numerous metabolic disturbances throughout the body . Therefore, we inferred that a reduction in the blood ammonia level could promote the functions of synthesis, secretion, and transformation in liver cells and simultaneously relieve the damage to liver cells. Recent studies showed that increasing ammonia concentrations had deleterious effects on the functions of the central nervous system and the elevation of arterial ammonia was associated with high mortality in patients with acute liver failure [10, 11]. Ammonia is a neurotoxin involved in the pathogenesis of neurological disease associated with hyperammonia . Hyperammonia following acute and chronic liver diseases may lead to HE, which is accompanied by the failure of energy metabolism , disturbances of neurotransmission in the brain, and changes in Na+-K+-ATPase [14, 15]. Moreover, our study showed that there was no change in Na+-K+-ATPase using gene chip assays, but arginine disappeared. Although the liver can convert ammonia to nontoxic urea through the urea cycle , the urea synthesis capacity is reduced in patients with liver disease, leading to a reduced capacity to detoxify ammonia in the liver. Besides, hyperammonia is also produced in urea cycle disorders and other conditions leading to either defective ammonium removal or overproduction of ammonium beyond the capacity of liver clearance . Therefore, we thought that ammonia might induce liver injury through another mechanism. However, there are few reports about whether increasing blood ammonia can lead to the damage of hepatocyte function observed in the present study. We also found that NH4Cl induced specific liver injury compared with other cell types and apoptosis of primary hepatocytes was significantly increased compared with control cells. In this study, we hypothesized that hyperammonia might directly induce a series of changes leading to liver injury. To verify this assumption, a hyperammonia cell model was established to investigate the effects of NH4Cl on liver damage and further examine the effects of NH4Cl on hepatocyte apoptosis.
Cell lines, cell culture, and NH4Cl treatment
Primary hepatocytes were purchased from the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). A-549 lung cancer cells, MCF-7 breast cells, BGC-823 gastric cancer cells, SKOV3 ovarian cancer cells, C6 glioma cells, and HepG2 HepG2.2.15 hepatocarcinoma cells were all preserved in our laboratory. All cells were maintained in RMPI1640 medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml streptomycin at 37°C under 5% CO2. The cells were treated with NH4Cl at 0.5, 5, 10, and 20 mmol/L.
Enzyme levels in media
The supernatant was extracted after exposed to 0 and 20 mM NH4Cl for 12, 24 and 48 h respectively. The detection of each indicator was carried out in accordance with the requirements of the ELISA kit. The OD values were detected at 450 nm with a Microplate reader (MultiskanMK3).
Viability was tested by using MTT (3-[4, 5-dimethyldiazol-2-yl]-2, 5–diphenyl -tetrazolium bromide) . After different concentrations of NH4CL exposure, MTT was added to a final concentration of 0.5 mg/ml. After 4 h MTT-incubation, supernatants were removed and 150 μL DMSO was added in each well, darkly shaken for 15 min. The absorption was measured by a microplate reader at a wavelength of 490 nm.
Apoptosis of different cell lines evaluated by flow cytometry
Cells were treated with NH4Cl, harvested after 24 hours and suspended in annexin V-binding buffer. Thereafter, the cells were incubated by FITC for 15 min in the dark, and propidium iodide was added. Thereafter, all samples were analyzed by a FACSCalibur flow cytometer with CellQuest software.
Assay of Na-K ATPase specific activity
Total membrane fractions were prepared from control and NH4Cl-treated hepatocytes and C6 cells. Reaction mixtures for Na-K-ATPase activity assay was as the manufacturer’s instructions (Jianchen Biology Engineering Institute, China). Enzymatic activity was measured as a function of liberated inorganic phosphate (P i) by the colorimetric reaction. The color developed after 10 min at 37°C and was read at a wavelength of 850 nm with a spectrophotometer (SpectraMax 190, Molecular Devices, Sunnyvale, CA).
Arginine levels after primary hepatocyte injury induced by NH4Cl
Primary hepatocytes were treated with 10 mmol/L NH4Cl for 24 h. We added 100ul sample cell fluid 350 μl extraction liquid (Vmethanol: Vchloroform = 3:1) and 50 μl L-2-Chlorophenylalanine as an internal standard and vortexed for 10 s. The samples were centrifuged for 10 min at 12,000 rpm and 4°C. Then we transferred 0.35 mL from the supernatant into a fresh 2 mL GC/MS glass vial. Next 80 mL methoxyamination reagent was added and shaken for 2 h at 37°C, followed by addition of 0.1 mL BSTFA reagent and shook for 1 h at 70°C. GC-MS analyses were performed when the temperatures cooled to room temperature.
Effects of BAPTA-AM and EGTA on primary hepatocyte injury induced by NH4Cl
Primary hepatocytes seeded in 96-well plates were treated with media containing various concentrations of NH4Cl for 1 h, followed by addition BAPTA-AM (1 × 10-5 mol/L). Next, NH4Cl and EGTA were added simultaneously. The control group was treated with solvent alone. MTT solution was added after BAPTA-AM for 6 h. Absorbance was measured at 450 nm using a microplate reader.
Detection of mitochondrial permeability transition pore (mPTP) opening
Primary hepatocytes were seeded in 48-well plates. After treatment with 20 mmol/L NH4Cl for 24 h, 500 μl GENMED reagent A preheated in 37°C was added to each well and then removed reagent A carefully. Then add 200 μl dyeing working fluid (5 μl reagent B plus 500 μl reagent C) was added to each well incubating at 37°C in cell culture box for 20 min darkly. Next we wash the cells with liquid A twice. Then images were collected as described. The cells were observed by fluorescence microscopy using an excitation wavelength of 488 nm and an emission wavelength of 505 nm. The peak shifting to the left indicated the increased activity of MPTP pore.
Analysis of mitochondrial morphology by transmission electron microscopy
Primary hepatocytes were treated with 0, 10, and 20 mM NH4Cl for 48 h. Then the cells were harvested, fixed in 2.5% glutaraldehyde, and embedded in propylene oxide and epoxy resin overnight at 37°C. The embedded cells were cut into ultrathin sections, double-stained with uranyl acetate and lead citrate, and observed by transmission electron microscopy.
RNA extraction and quantitative real-time PCR
Total RNA was extracted from primary hepatocytes after 12, 24, and 48 h of NH4Cl treatment using the TRIzol reagent (Takara, Japan). First-strand cDNA was synthesized from 1 μg total RNA using a PrimeScript RT Reagent Kit With gDNA Eraser. The cDNA was used to detect the expression levels of caspase-3, cytochrome C (Cyt C), calmodulin, and inducible nitric oxide synthase (iNOS). Quantitative real-time PCR was performed using SYBR Premix Ex Taq II in a Step One Plus system.
Western blot analysis
To extract the total proteins, livers or cells which were treated with NH4Cl were lysed on ice for 30 min in lyses buffer , and centrifuged at 12000 g for 10 min, the supernatant were recovered. After denaturation, 50 μg proteins were separated on 10% SDS/PAGE gels and then transferred to nitrocellulose membranes by using a transfer cell system (Bio-Rad, California, USA). Membranes were blocked for 1 h at room temperature with 5% nonfat dried milk powder/Tris-buffered saline Tween-20 (TBST) and then with primary antibodies incubated overnight at 4°C. Immunoblots were washed 3 times with TBST and were incubated with secondary antibodies conjugated with horseradish peroxidase against mouse IgG or rabbit IgG for 1 h at room temperature. Immunoreactive proteins were visualized using the infrared laser scanning imaging system (CDYSSEY CLx; General Electric Company).
Statistical analysis was performed with SPSS 13.0 software (SPSS Inc., Chicago, IL, USA). Data are expressed as means ± SD, and three individual experiments were carried out in triplicate. The Student’s t-test was used to compare data between two groups. One-way ANOVA and Dunnett’s test were used to compare data between three or more groups. P < 0.05 was considered to indicate a statistically significant result.
Hyperammonia induces specific inhibition of liver regeneration
Liver damage caused by ALT and AST in vitro
Effects of NH4Cl on cell growth in cell lines
NH4Cl-induced apoptosis in primary hepatocytes
Roles of caspase-3, Cyt C, and bcl-2 in liver regeneration
Differences in liver damage induced by hyperammonia between liver cells and other cells
Activity of Na-K ATPase
To elucidate the differences in Na-K-ATPase activity between liver cells and astrocytes, we measured the Na-K-ATPase activity in membrane fractions of liver cells and astrocytes treated with 20 mM NH4Cl. In the liver cells, the Na-K-ATPase activity was no significant difference (control group: 11.4 ± 4.5 nmol Pi/μg protein/min NH4Cl-treated group 12.8 ± 2.9 nmol Pi/μg protein/min). However, in the astrocytes, the Na-K-ATPase activity was significantly increased in NH4Cl-treated group (control group: 13.9 ± 3.6 nmol Pi/μg protein/min NH4Cl-treated group: 47.6 ± 2.9 nmol Pi/μg protein/min).
Arginine level after primary hepatocyte injury induced by NH4Cl
Compared with the control group, the arginine level was decreased in the NH4Cl-treated group (0.0003023 ± 0.3271), representing 69.16 ± 0.4179% of the arginine level in the control group (0.0004372 ± 0.2146).
Hyperammonia induces mitochondrial damage
Hyperammonia induces the change of morphologic features of mitochondria
To investigate the mechanism of the liver damage induced by hyperammonia, we examined the morphological features of mitochondria by transmission electron microscopy. We observed the changes in the mitochondria depending on the ammonia exposure with 10 and 20 mmol/L. The mitochondria showed irregular swelling, fractured cristae, and vacuolar degeneration (Figure 6A).
Effects of BAPTA-AM and EGTA on primary hepatocyte injury induced by hyperammonia
We observed that the cell viability was increasd (51.83 ± 2.30%) after BAPTA-AM treatment (Figure 2C) compaired with the control group (76.51 ± 1.96%) which was only treated with 100 mmol/L NH4Cl. Each value is shown as the mean ± SEM, after normalization by the control for each concentration. In contrast, the cell viability of primary hepatocytes was unchanged after EGTA addition.
Hyperammonia triggers mPTP opening
Treatment of hepatocytes with 20 mM ammonia (48 h) caused the position of peak shift move to left, but the position of peak shift has little change in control group(as shown in Figure 4B: C1 and T1). Comparison of C1 and C2, the position of peak shift move to left enhanced membrane channel activity (Figure 6B: T1, T2 and T3).
Hyperammonia induces apoptosis through an intrinsic Ca2+-independent apoptosis pathway
We examined the effects of NH4Cl on apoptosis through an intrinsic Ca2+-independent apoptosis pathway by measuring levels of calmodulin and iNOS. The results of WB are consistent with QT-PCR. The energy barrier caused by ammonia increased the expression of calmodulin and iNOS (Figure 5B). As depicted in Figures 4 and 5B, the mRNA expression of the molecules did not change after treatment with NH4Cl for 12 h (p > 0.05; data obtained from three independent experiments) and were significantly increased after treating with 20 mmol/L NH4Cl for 24 h. The protein expressions were significantly changed after NH4Cl treatment for 48 h and then returned to the control levels at 72 h. The results showed that the most significantly increased expressions of calmodulin (2.34 ± 0.31) and iNOS (2.46 ± 0.14) were observed after treatment with NH4Cl at 10 mmol/L for 48 h.
Numerous pathological processes which affect liver function in patients with liver failure have been identified. Among them, hyperammonia is one of the most common phenomena. It is well known that many growth factors and cytokines have explicit effects on regulating liver regeneration . However, it remains unclear whether hyperammonia has an effect on liver injury. Currently, most researchers believe that ammonia is a kind of toxicant which can inhibit many cell functions, such as cell regeneration. In our studies, we showed that hyperammonia could induce specific liver injury, while liver damage could elevate the concentration of blood ammonia.
In agreement with previous work [20, 21], our study demonstrated that NH4Cl induced liver damage, resulting in considerable cytotoxicity, and showed that the ALT and AST levels were increased because of the cytotoxicity against regenerating hepatocytes, which are biomarkers of pathological changes in the liver . We also investigated the toxicity of ammonia to hepatocytes. With the increased concentration and time of ammonia exposed to hepatocytes, significant differences were found in the cell viability, indicating hepatocytes were sensitive to ammonia toxicity (Figure 2A and B). Many studies have focused on the neurotoxicity of ammonia, however, ammonia is not toxic to all cells. Hassel T et al.  found different cells show different growth inhibition when exposed to the same concentrations of ammonia. It suggested that the effect of ammonia on cells has significant cell specificity. Our study demonstrated only hepatocytes were inhibited, as evaluated by exposing various cell lines to NH4Cl. Furthermore, the apoptosis rates in the hyperammonia group of primary hepatocytes were significantly higher than those in the control group, especially when the concentrations of NH4Cl were 20 mmol/L. However, the apoptosis rates for hyperammonia of other cell lines showed no differences. To eliminate the influence of the pH value in our study, we adjusted the different NH4Cl concentrations with dilute hydrochloric acid solution to the same pH values.We found that the pH value had no effects on the cytotoxicity and apoptosis (Figure 3B).
Investigators now believe that hyperammonia is a major factor in HE, which is associated with liver disease . HE represents a broad continuum of neuropsychological dysfunctions in patients with acute or chronic liver disease. The pathophysiology of the disease is complex, which involves overproduction and reduced metabolism of various neurotoxins, particularly ammonia . Currently, there are different theories about HE [26, 27], and the majority of studies have focused on ammonia poisoning. In the present study, we found that hyperammonia could lead to different expression of some important genes, such as glucose transporter (GLUT-1), glycine transporter (GLYT-1), Na+-K+-ATPase [28, 29]. However, in our previous study, we found that Na+-K+-ATPase showed no difference under hyperammonia conditions in gene chip assays, while arginine was decreased . Furthermore, we found that the activity of Na+-K+-ATPase in hepatocytes under hyperammonia did not significantly differ from the control level, but it was decreased in astrocytes. Therefore, we consider that the mechanism of the liver damage induced by hyperammonia differs from that in HE.
To investigate the mechanism of the liver damage induced by hyperammonia, we measured the mitochondrial in hepatocytes. With increasing concentration of ammonia, the morphologic of mitochondrion began to be abnormalities (swelling and turn round, Crista disorder, vacuolar degeneration) (Figure 6A). To further examine the function of mitochondrion, we measured the mPTP by calcein fluorescence, we found that ammonia induced opening of mPTP after exposed to ammonia (Figure 6B). The mPTP, which represents the increaseing in the permeability of mitochondrion, is a protein pore which is formed in the inner membrane of the mitochondria under certain pathological conditions [31, 32].
In summary, based on the model of liver cell damage resulting from NH4Cl, the present study has revealed that increased NH4Cl may intensify liver injury, in a manner which was specific for concentration and time. The mechanism possibly involves mitochondrial damage through activation of an intrinsic Ca2+-independent apoptosis pathway. It appears that therapeutic approaches to inhibit the concentration of NH4Cl and rebalance apoptosis might be efficacious in preventing NH4Cl-induced liver damage.
The authors thank Dr. Quancheng Kan and Dr. Zujiang Yu for support and excellent technical assistance during the experiments and paper writing. No external fund was used in carrying out this investigation.
- Ellis A, Wendon J: Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: pathophysiology and management. Semin Liver Dis. 1996, 16: 379-388. 10.1055/s-2007-1007251.View ArticlePubMedGoogle Scholar
- Sandgren EP, Palmiter RD, Heckel JL, Sandgren EP, Palmiter RD, Heckel JL, Daugherty CC, Brinster RL, Degen JL: Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell. 1991, 66: 245-256. 10.1016/0092-8674(91)90615-6.View ArticlePubMedGoogle Scholar
- Overturf K, Al-Dhalimy M, Finegold M, Grompe M: The repopulation potential of hepatocyte populations differing in size and prior mitotic expansion. Am J Pathol. 1999, 155: 2135-2143. 10.1016/S0002-9440(10)65531-9.View ArticlePubMedPubMed CentralGoogle Scholar
- Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS, Greenberger JS, Goff JP: Bone marrow as a potential source of hepatic oval cells. Science. 1999, 284: 1168-1170. 10.1126/science.284.5417.1168.View ArticlePubMedGoogle Scholar
- Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, Wang X, Finegold M, Weissman IL, Grompe M: Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000, 6: 1229-1234. 10.1038/81326.View ArticlePubMedGoogle Scholar
- Bohm F: Regulation of liver regeneration by growth factors and cytokines. EMBO Mol Med. 2010, 2: 294-305. 10.1002/emmm.201000085.View ArticlePubMedPubMed CentralGoogle Scholar
- Taub R: Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol. 2004, 5: 836-847. 10.1038/nrm1489.View ArticlePubMedGoogle Scholar
- Lange CM, Bojunga J, Hofmann WP, Wunder K, Mihm U, Zeuzem S, Sarrazin C: Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function. Hepatology. 2009, 50: 2001-2006. 10.1002/hep.23346.View ArticlePubMedGoogle Scholar
- Widmer R, Kaiser B, Engels M, Wunder K, Mihm U, Zeuzem S, Sarrazin C: Hyperammonemia causes protein oxidation and enhanced proteasomal activity in response to mitochondria-mediated oxidative stress in rat primary astrocytes. Arch Biochem Biophys. 2007, 464: 1-11. 10.1016/j.abb.2007.03.027.View ArticlePubMedGoogle Scholar
- Felipo V, Butterworth RF: Neurobiology of ammonia. Prog Neurobiol. 2002, 67: 259-279. 10.1016/S0301-0082(02)00019-9.View ArticlePubMedGoogle Scholar
- Drolz A, Jäger B, Wewalka M, Saxa R, Horvatits T, Roedl K, Perkmann T, Zauner C, Kramer L, Ferenci P, Fuhrmann V: Clinical impact of arterial ammonia levels in ICU patients with different liver diseases. Intensive Care Med. 2013, 39: 1227-1237. 10.1007/s00134-013-2926-8.View ArticlePubMedGoogle Scholar
- Skowronska M, Albrecht J: Alterations of blood brain barrier function in hyperammonemia: an overview. Neurotox Res. 2012, 21: 236-244. 10.1007/s12640-011-9269-4.View ArticlePubMedGoogle Scholar
- Rao KV, Norenberg MD: Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia. Metab Brain Dis. 2001, 16: 67-78. 10.1023/A:1011666612822.View ArticlePubMedGoogle Scholar
- Rao VL, Murthy CR, Butterworth RF: Glutamatergic synaptic dysfunction in hyperammonemic syndromes. Metab Brain Dis. 1992, 7: 1-20. 10.1007/BF01000437.View ArticlePubMedGoogle Scholar
- Hazell AS, Butterworth RF: Hepatic encephalopathy: An update of pathophysiologic mechanisms. Proc Soc Exp Biol Med. 1999, 222: 99-112. 10.1046/j.1525-1373.1999.d01-120.x.View ArticlePubMedGoogle Scholar
- Kim IK, Niemi AK, Krueger C, Bonham CA, Concepcion W, Cowan TM, Enns GM, Esquivel CO: Liver transplantation for urea cycle disorders in pediatric patients: a single-center experience. Pediatr Transplant. 2013, 17: 158-167. 10.1111/petr.12041.View ArticlePubMedGoogle Scholar
- Adeva MM: Ammonium metabolism in humans. Metabolism. 2012, 61: 1495-1511. 10.1016/j.metabol.2012.07.007.View ArticlePubMedGoogle Scholar
- Oka M, Maeda S, Koga N, Kato K, Saito T: A modified colorimetric MTT assay adapted for primary cultured hepatocytes: application to proliferation and cytotoxicity assays. Biosci Biotechnol Biochem. 1992, 56: 1472-1473. 10.1271/bbb.56.1472.View ArticlePubMedGoogle Scholar
- Li Volti G, Wang J, Traganos F, Kappas A, Abraham NG: Differential effect of heme oxygenase-1 in endothelial and smooth muscle cell cycle progression. Biochem Biophys Res Commun. 2002, 296: 1077-1082. 10.1016/S0006-291X(02)02054-5.View ArticlePubMedGoogle Scholar
- Chastre A, Jiang W, Desjardins P, Butterworth RF: Ammonia and proinflammatory cytokines modify expression of genes coding for astrocytic proteins implicated in brain edema in acute liver failure. Metab Brain Dis. 2010, 25: 17-21. 10.1007/s11011-010-9185-y.View ArticlePubMedGoogle Scholar
- Jayakumar AR, Panickar KS, Murthy CR, Norenberg MD: Oxidative stress and mitogen-activated protein kinase phosphorylation mediate ammonia-induced cell swelling and glutamate uptake inhibition in cultured astrocytes. J Neurosci. 2006, 26: 4774-4784. 10.1523/JNEUROSCI.0120-06.2006.View ArticlePubMedGoogle Scholar
- Adams LA, Angulo P, Lindor KD: Nonalcoholic fatty liver disease. CMAJ. 2005, 172: 899-905. 10.1503/cmaj.045232.View ArticlePubMedPubMed CentralGoogle Scholar
- Hassell T, Glevae S, Butler M: Growth inhibition in animal cell culture. Appl Biochem Biotechnol. 1991, 30: 29-41. 10.1007/BF02922022.View ArticlePubMedGoogle Scholar
- Brusilow SW, Koehler RC, Traystman RJ, Cooper AJ: Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics. 2010, 7: 452-470. 10.1016/j.nurt.2010.05.015.View ArticlePubMedPubMed CentralGoogle Scholar
- Garcovich M, Zocco MA, Roccarina D, Ponziani FR, Gasbarrini A: Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota. World J Gastroenterol. 2012, 18: 6693-6700. 10.3748/wjg.v18.i46.6693.View ArticlePubMedPubMed CentralGoogle Scholar
- Jones EA, Mullen KD: Theories of the pathogenesis of hepatic encephalopathy. Clin Liver Dis. 2012, 16: 7-26. 10.1016/j.cld.2011.12.010.View ArticlePubMedGoogle Scholar
- Atluri DK, Prakash R, Mullen KD: Pathogenesis, diagnosis, and treatment of hepatic encephalopathy. J Clin Exp Hepatol. 2011, 1: 77-86. 10.1016/S0973-6883(11)60126-6.View ArticlePubMedPubMed CentralGoogle Scholar
- Kala G, Kumarathasan R, Peng L, Leenen FH, Hertz L: Stimulation of Na+, K + -ATPase activity, increase in potassium uptake, and enhanced production of ouabain-like compounds in ammonia-treated mouse astrocytes. Neurochem Int. 2000, 36: 203-211. 10.1016/S0197-0186(99)00117-5.View ArticlePubMedGoogle Scholar
- Xue Z, Li B, Gu L, Hu X, Li M, Butterworth RF, Peng L: Increased Na, K-ATPase alpha2 isoform gene expression by ammonia in astrocytes and in brain in vivo. Neurochem Int. 2010, 57: 395-403. 10.1016/j.neuint.2010.04.014.View ArticlePubMedGoogle Scholar
- Jia B, Zujiang Y, Zhenfeng D, Lü XQ, Li JJ, Liu XR, Sun R, Gao XJ, Wang YF, Yan JY, Kan QC: Hyperammonaemia induces hepatic injury with alteration of gene expression profiles. Liver Int. 2014, 34 (5): 748-758. 10.1111/liv.12365.View ArticlePubMedGoogle Scholar
- BERNARDI P, FORTE M: The mitochondrial permeability transition pore. Novartis Found Symp. 2007, 287: 157-164. discussion 64-9View ArticlePubMedGoogle Scholar
- Bernardi P: The mitochondrial permeability transition pore: a mystery solved?. Front Physiol. 2013, 4: 95-View ArticlePubMedPubMed CentralGoogle Scholar
- Julie NL, Julie IM, Kende AI, Wilson GL: Mitochondrial dysfunction and delayed hepatotoxicity: another lesson from troglitazone. Diabetologia. 2008, 51: 2108-2116. 10.1007/s00125-008-1133-6.View ArticlePubMedGoogle Scholar
- Kessova IG, Cederbaum AI: Mitochondrial alterations in livers of Sod1-/- mice fed alcohol. Free Radic Biol Med. 2007, 42: 1470-1480. 10.1016/j.freeradbiomed.2007.01.044.View ArticlePubMedPubMed CentralGoogle Scholar
- Kim JH, Choi S, Jung JE, Roh EJ, Kim HJ: Capacitative Ca2+ entry is involved in regulating soluble amyloid precursor protein (sAPPalpha) release mediated by muscarinic acetylcholine receptor activation in neuroblastoma SH-SY5Y cells. J Neurochem. 2006, 97: 245-254. 10.1111/j.1471-4159.2006.03734.x.View ArticlePubMedGoogle Scholar
- Jang YJ, Ryu HJ, Choi YO, Kim C, Leem CH, Park CS: Improvement of insulin sensitivity by chelation of intracellular Ca(2+) in high-fat-fed rats. Metabolism. 2002, 51: 912-918. 10.1053/meta.2002.33351.View ArticlePubMedGoogle Scholar
- Wu G, Morris SM: Arginine metabolism: nitric oxide and beyond. Biochem J. 1998, 336: 1-17.View ArticlePubMedPubMed CentralGoogle Scholar
- Lowenstein CJ, Dinerman JL, Snyder SH: Nitric oxide: a physiologic messenger. Ann Intern Med. 1994, 120: 227-237. 10.7326/0003-4819-120-3-199402010-00009.View ArticlePubMedGoogle Scholar
- Yamaguchi M: The anti-apoptotic effect of regucalcin is mediated through multisignaling pathways. Apoptosis. 2013, 18: 1145-1153. 10.1007/s10495-013-0859-x.View ArticlePubMedPubMed CentralGoogle Scholar
- Huttemann M, Pecina P, Rainbolt M, Sanderson TH, Kagan VE, Samavati L, Doan JW, Lee I: The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: From respiration to apoptosis. Mitochondrion. 2011, 11: 369-381. 10.1016/j.mito.2011.01.010.View ArticlePubMedPubMed CentralGoogle Scholar
- Wang X: The expanding role of mitochondria in apoptosis. Genes Dev. 2001, 15: 2922-2933.PubMedGoogle Scholar
- Green DR: Apoptotic pathways: paper wraps stone blunts scissors. Cell. 2000, 102: 1-4. 10.1016/S0092-8674(00)00003-9.View ArticlePubMedGoogle Scholar
- Li K, Li Y, Shelton JM, Richardson JA, Spencer E, Chen ZJ, Wang X, Williams RS: Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis. Cell. 2000, 101: 389-399. 10.1016/S0092-8674(00)80849-1.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-230X/14/151/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.